Announcements Trials
Browse Landscape

Status

Completed 2

Sponsor Class

OTHER 3INDUSTRY 2NIH 1

Study Type

Observational 2

Sponsor

Conditions

Breast Neoplasms 468Neoplasms 316Carcinoma, Non-Small-Cell Lung 269Prostatic Neoplasms 215Colorectal Neoplasms 208Lung Neoplasms 178Multiple Myeloma 123Melanoma 110Carcinoma, Renal Cell 107Ovarian Neoplasms 94Carcinoma, Hepatocellular 78Pancreatic Neoplasms 69Urinary Bladder Neoplasms 65Stomach Neoplasms 64Neoplasm Metastasis 64Leukemia, Lymphocytic, Chronic, B-Cell 62Colonic Neoplasms 60Leukemia, Myeloid, Acute 53Uterine Cervical Neoplasms 50Recurrence 49Liver Neoplasms 46Lymphoma, Follicular 45Lymphoma 45Leukemia, Myelogenous, Chronic, BCR-ABL Positive 39Esophageal Neoplasms 37Precursor Cell Lymphoblastic Leukemia-Lymphoma 36Lymphoma, Large B-Cell, Diffuse 35Hematologic Neoplasms 35Head and Neck Neoplasms 35Lymphoma, Non-Hodgkin 34

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
INDUSTRY × Observational × Spinal Neoplasms × Clear all
NCT02931279 2023-11-27

PASS OCT® Post-market Clinical Follow-up

Medicrea International

Completed
40 enrolled

Intervertebral disc disease, Spinal Neoplasms, Spinal Stenosis, Spondylolisthesis, Spinal Fractures

NCT02926391 2023-05-03

UNiD 3D VBR Register

Medicrea International

Completed
12 enrolled

Bone Diseases, Infectious, Spinal Cord Compression, Spinal Neoplasms, Ossification of Posterior Longitudinal Ligament, Spondylosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡